Craig Swearingen

622 total citations
21 papers, 423 citations indexed

About

Craig Swearingen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Craig Swearingen has authored 21 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Craig Swearingen's work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Craig Swearingen is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Craig Swearingen collaborates with scholars based in United States, Canada and Australia. Craig Swearingen's co-authors include Kannan Thirunavukkarasu, Gary DeCrescenzo, Grace E. Munie, Daniel P. Becker, M.G. Chambers, Susan L. Hockerman, John N. Freskos, Daniel P. Getman, Chaohua Lin and Joseph J. McDonald and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Lipid Research and Clinical Orthopaedics and Related Research.

In The Last Decade

Craig Swearingen

21 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig Swearingen United States	15	182	113	107	97	82	21	423
M. Anthony Leesnitzer United States	10	288 1.6×	65 0.6×	122 1.1×	179 1.8×	45 0.5×	11	536
Grace E. Munie United States	14	212 1.2×	59 0.5×	222 2.1×	204 2.1×	95 1.2×	17	478
Jonathan Tart United Kingdom	8	283 1.6×	30 0.3×	115 1.1×	83 0.9×	43 0.5×	9	396
J.S. Skotnicki United States	6	137 0.8×	27 0.2×	102 1.0×	148 1.5×	56 0.7×	8	311
Andrea Uecker Germany	9	207 1.1×	26 0.2×	45 0.4×	82 0.8×	119 1.5×	12	457
Vincent Bordas United Kingdom	8	511 2.8×	39 0.3×	48 0.4×	125 1.3×	280 3.4×	14	836
Aaron Maurais United States	7	204 1.1×	52 0.5×	56 0.5×	71 0.7×	80 1.0×	8	364
Jean Shearin United States	8	132 0.7×	76 0.7×	35 0.3×	51 0.5×	139 1.7×	8	427
Henri Wichmann Germany	16	375 2.1×	54 0.5×	202 1.9×	107 1.1×	39 0.5×	20	561
Fay Young United States	8	314 1.7×	32 0.3×	78 0.7×	169 1.7×	19 0.2×	9	534

Countries citing papers authored by Craig Swearingen

Since Specialization

Citations

This map shows the geographic impact of Craig Swearingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Swearingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Swearingen more than expected).

Fields of papers citing papers by Craig Swearingen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Swearingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Swearingen. The network helps show where Craig Swearingen may publish in the future.

Co-authorship network of co-authors of Craig Swearingen

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Swearingen. A scholar is included among the top collaborators of Craig Swearingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Swearingen. Craig Swearingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Swearingen, Craig, John H. Sloan, Robert W. Siegel, et al.. (2024). Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin. Journal of Lipid Research. 66(1). 100723–100723. 3 indexed citations

Calderón, Boris, et al.. (2023). A Monovalent Fab Affinity-Capture and Elution Bridging Immunoassay Overcomes Rheumatoid Factor Interference while Accurately Detecting Antidrug Antibodies. The Journal of Applied Laboratory Medicine. 8(5). 896–908. 1 indexed citations

Bivi, Nicoletta, Craig Swearingen, John H. Sloan, et al.. (2020). Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity. Journal of Immunological Methods. 486. 112856–112856. 8 indexed citations

Bivi, Nicoletta, Terry L. Moore, George H. Rodgers, et al.. (2019). Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk. mAbs. 11(5). 861–869. 19 indexed citations

Durham, Timothy B., Chin Liu, Daniel R. Mudra, et al.. (2017). A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose. Journal of Medicinal Chemistry. 60(13). 5933–5939. 12 indexed citations

Thirunavukkarasu, Kannan, Craig Swearingen, J.L. Oskins, et al.. (2016). Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain. Osteoarthritis and Cartilage. 25(6). 935–942. 16 indexed citations

Jones, Spencer B., Lance A. Pfeifer, Thomas J. Bleisch, et al.. (2016). Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design. ACS Medicinal Chemistry Letters. 7(9). 857–861. 39 indexed citations

Thirunavukkarasu, Kannan, Bo Tan, Craig Swearingen, et al.. (2016). Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis. Journal of Pharmacology and Experimental Therapeutics. 359(1). 207–214. 25 indexed citations

Haller, Justin M., et al.. (2015). Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture. Clinical Orthopaedics and Related Research. 473(10). 3280–3288. 25 indexed citations

10.

Durham, Timothy B., Valentine J. Klimkowski, Christopher J. Rito, et al.. (2014). Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis. Journal of Medicinal Chemistry. 57(24). 10476–10485. 21 indexed citations

11.

Swearingen, Craig, M.G. Chambers, Chaohua Lin, et al.. (2010). A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs. Osteoarthritis and Cartilage. 18(9). 1159–1166. 21 indexed citations

12.

Kolodziej, Stephen A., Susan L. Hockerman, Terri L. Boehm, et al.. (2010). Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective α-sulfone hydroxamates. Bioorganic & Medicinal Chemistry Letters. 20(12). 3557–3560. 15 indexed citations

13.

Swearingen, Craig, John W. Carpenter, Robert W. Siegel, et al.. (2010). Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine. Osteoarthritis and Cartilage. 18(9). 1150–1158. 33 indexed citations

14.

Kolodziej, Stephen A., Susan L. Hockerman, Gary DeCrescenzo, et al.. (2010). MMP-13 selective isonipecotamide α-sulfone hydroxamates. Bioorganic & Medicinal Chemistry Letters. 20(12). 3561–3564. 22 indexed citations

15.

Dotzlaf, Joe E., Craig Swearingen, Isabelle J. Brittain, et al.. (2007). Development and characterization of a novel ELISA based assay for the quantitation of sub-nanomolar levels of neoepitope exposed NITEGE-containing aggrecan fragments. Journal of Immunological Methods. 328(1-2). 162–168. 14 indexed citations

16.

Becker, Daniel P., Clara I. Villamil, Thomas E. Barta, et al.. (2005). Synthesis and Structure−Activity Relationships of β- and α-Piperidine Sulfone Hydroxamic Acid Matrix Metalloproteinase Inhibitors with Oral Antitumor Efficacy. Journal of Medicinal Chemistry. 48(21). 6713–6730. 51 indexed citations

17.

Becker, Daniel P., Gary DeCrescenzo, John N. Freskos, et al.. (2001). α-Alkyl-α-amino-β-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1. Bioorganic & Medicinal Chemistry Letters. 11(20). 2723–2725. 19 indexed citations

18.

Becker, Daniel P., Thomas E. Barta, Louis J. Bedell, et al.. (2001). α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1. Bioorganic & Medicinal Chemistry Letters. 11(20). 2719–2722. 27 indexed citations

19.

Freskos, John N., Gary DeCrescenzo, R. Heintz, et al.. (1999). Discovery of a novel series of selective MMP inhibitors: Identification of the γ-sulfone-thiols. Bioorganic & Medicinal Chemistry Letters. 9(7). 943–948. 21 indexed citations

20.

Woulfe, Susan L., Christine P. Bono, Dawn A. Kirschmann, et al.. (1995). Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis & Rheumatism. 38(12). 1744–1753. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact